Anatara Lifesciences Limited Stock Market Press Releases and Company Profile

Sydney, July 24, 2019 AEST (ABN Newswire) - Anatara's CEO, Steve Lydeamore will be presenting to investors during the Bioshares Biotech Summit this Friday, and at a Monsoon Communications Twilight Investor Briefing event in Melbourne during August. Any investors interested in attending these presentations are invited to reach out.

Details and registration links are summarised below:

Bioshares Biotech Summit

Steve will speak in a session on Gut and the Microbiome alongside Microba and Atmo Biosciences:

* Friday, 26th July 2019
* 5:00pm to 6:00pm
* Skyline, Queenstown, New Zealand

To see the Bioshares program and event information, visit:
http://www.bioshares.com.au/program2019.htm

Monsoon Communications Twilight Investor Briefing

Steve will provide an update on Anatara's work in gastrointestinal health for both humans and animals, alongside AdAlta Ltd:

* Thursday 22nd August 2019
* 4.15pm for 4.30pm
* FB Rice Boardroom, Level 14, 90 Collins Street, Melbourne

To register, contact info@monsoon.com.au

About Anatara Lifesciences Limited

Anatara Lifesciences ASX ANRAnatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing productsfor human and animal health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders. 

 

https://twitter.com/anataraanr https://www.facebook.com/profile.php?id=61550997392627 https://www.linkedin.com/company/anatara-lifesciences-ltd abnnewswire.com 


Contact

Investor and Media inquiries

Steven Lydeamore
Chief Executive Officer
Anatara Lifesciences Ltd
T: +61-438-027-172
E: slydeamore@anatara.com

Sue MacLeman
Chair
Anatara Lifesciences Ltd
T: +61-437-211-200
E: smacleman@anatara.com


ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 13) (Last 30 Days: 30) (Since Published: 4030)